Researchers at the Yale University School of Medicine have shown that an antibody that was originally isolated from a mouse model of lupus may be useful as a targeted cancer therapy.
Intellectual property (IP) is a cornerstone of the drug discovery industry. But as that industry is changing, some are questioning whether that cornerstone is starting to do more harm than good, at least the way it currently is constructed.
Through a procedure known as spindle transfer, or spindle complex-chromosomal transfer, scientists have created human eggs composed of the nuclear DNA from one person and the mitochondrial DNA from another.
Researchers from the Australian Mater Medical Research Institute, the University of Brisbane and U.S. biotech company GlycoMimetics Inc. have reported new insights into how blood stem cells are activated by selectins, and how blocking that activation may be able to protect them from the effects of chemotherapy and radiation.
By screening a thousand FDA-approved drugs in a multistep process, scientists have identified a set of drug combinations that work synergistically to inhibit HIV replication.
NEW ORLEANS – Lemming myths aside, suicide is one behavior that cannot be modeled in animal studies. But some of the risk factors that increase suicide risk in humans can.
NEW ORLEANS – During her professional life, Barbara Sahakian told the audience on Monday at the 2012 annual meeting of the Society for Neuroscience, the approach to mental health problems has undergone a "shift from attempts to treat chronic relapsing mental health problems after they occur to an attempt to prevent them . . . or at least detect early and treat effectively."
On Wednesday, the 2012 Nobel Prize in Chemistry once again went for discoveries that would not have been surprising to see honored with Monday's Prize in Physiology or Medicine. It was awarded to Duke University's Robert Lefkowitz and Stanford University's Brian Kobilka "for studies of G-protein-coupled receptors."
